Zahra Jorjoran Shushtari, Yahya Salimi, Sina Ahmadi, Nader Rajabi-Gilan, Marzieh Shirazikhah, Akbar Biglarian, Ali Almasi, Mohammad Ali Mohammadi Gharehghani
Osong Public Health Res Perspect. 2021;12(6):346-360. Published online December 21, 2021
Adherence to coronavirus disease 2019 (COVID-19) preventive guidelines (ACPG) is an important strategy to control the COVID-19 pandemic effectively. The present study aimed to identify and summarize the social determinants of ACPG among the general population. A comprehensive review was performed from December 2019 to February 2021 through searching electronic databases. Two independent reviewers assessed and selected relevant studies. Next, the characteristics and main findings of the included studies were summarized. Finally, the World Health Organization’s conceptual framework of social determinants of health was used to synthesize the identified social determinants of ACPG. Forty-one of 453 retrieved articles met the inclusion criteria. The study results showed different patterns of ACPG among various communities. Furthermore, 84 social determinants were identified and categorized into structural and intermediary determinants. ACPG is a set of complex behaviors associated with different individual sociodemographic and behavioral characteristics; living and working conditions; COVID-19 knowledge, attitudes, and risk perceptions; exposure to sources and information level; leisure activities; social support; trust; social norms; psychosocial well-being; socio-economic position; and the socio-economic and political context. Interventions to promote ACPG among the general population should consider the identified social determinants of ACPG.
Citations
Citations to this article as recorded by
Utilisation of rehabilitation due to mental disorders during the SARS-CoV-2 pandemic: a difference-in-differences analysis Matthias Bethge, David Fauser, Pia Zollmann, Marco Streibelt BMC Psychiatry.2023;[Epub] CrossRef
Perceptions about COVID-19 preventive measures among Ghanaian women Frank Kyei-Arthur, Martin Wiredu Agyekum, Grace Frempong Afrifa-Anane, Reuben Tete Larbi, Peter Kisaakye, Dario Ummarino PLOS ONE.2023; 18(4): e0284362. CrossRef
Cognitive and Emotional Motivation to Explain Infection-Prevention Behaviors with Social Support as a Mediator During the COVID-19 Pandemic: A Nationwide Cross-Sectional Study in Korea Myonghwa Park, Keunyeob Oh, Hyungjun Kim, Xing Fan, Thi-Thanh-Thnh Giap, Rhayun Song Patient Preference and Adherence.2023; Volume 17: 1063. CrossRef
Factors Influencing COVID-19 Prevention Behavior: A Community-based Cross-sectional Study Ernawaty Ernawaty, Nabilla Belqys Dherindri Open Access Macedonian Journal of Medical Sciences.2023; 11(E): 191. CrossRef
Social Determinants of Adherence to COVID-19 Preventive Guidelines in Iran: A Qualitative Study Sina Ahmadi, Zahra Jorjoran Shushtari, Marzieh Shirazikhah, Akbar Biglarian, Seyed Fahim Irandoost, Toktam Paykani, Ali Almasi, Nader Rajabi-Gilan, Nafiul Mehedi, Yahya Salimi INQUIRY: The Journal of Health Care Organization, .2022; 59: 004695802210841. CrossRef
Determinants of observing health protocols related to preventing COVID-19 in adult women: A qualitative study in Iran Javad Yoosefi Lebni, Saeede Pavee, Mandana Saki, Arash Ziapour, Ahmad Ahmadi, Mehdi Khezeli Frontiers in Public Health.2022;[Epub] CrossRef
Adherence to Coronavirus Disease 2019 Preventive Measures in a Representative Sample of the Population of the Canton of Vaud, Switzerland Audrey Butty, Nolwenn Bühler, Jérôme Pasquier, Julien Dupraz, Vincent Faivre, Sandrine Estoppey, Cloé Rawlinson, Semira Gonseth Nusslé, Murielle Bochud, Valérie D’Acremont International Journal of Public Health.2022;[Epub] CrossRef
Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members Anna Hudson, Peter A. Hall, Sara C. Hitchman, Gang Meng, Geoffrey T. Fong Vaccine.2022;[Epub] CrossRef
Quarantine preparedness – the missing factor in COVID-19 behaviour change? Qualitative insights from Australia Angela Davis, Stephanie Munari, Joseph Doyle, Brett Sutton, Allen Cheng, Margaret Hellard, Lisa Gibbs BMC Public Health.2022;[Epub] CrossRef
The impact of COVID-19 pandemic on hospital admissions for nine diseases in Iran: insight from an interrupted time series analysis Sina Ahmadi, Ali Kazemi-Karyani, Nasim Badiee, Sarah Byford, Ali Mohammadi, Bakhtiar Piroozi, Satar Rezaei Cost Effectiveness and Resource Allocation.2022;[Epub] CrossRef
Psychosocial Determinants of Hand Hygiene, Facemask Wearing, and Physical Distancing During the COVID-19 Pandemic: A Systematic Review and Meta-analysis Wei Liang, Yanping Duan, Feifei Li, Ryan E Rhodes, Xiang Wang, Dehiwala Liyanage Ishanka Harshani Kusum Peiris, Lin Zhou, Borui Shang, Yide Yang, Julien S Baker, Jiao Jiao, Wei Han Annals of Behavioral Medicine.2022; 56(11): 1174. CrossRef
Objectives The coronavirus disease 2019 (COVID-19) pandemic has set a precedent for the fastest-produced vaccine as a result of global collaboration and outreach. This study explored Malaysians’ acceptance of the COVID-19 vaccine and its associated factors.
Methods A cross-sectional anonymous web-based survey was disseminated to Malaysian adults aged ≥18 years old via social media platforms between July 10, 2020 and August 31, 2020.
Results In the analysis of 4,164 complete responses, 93.2% of participants indicated that they would accept the COVID-19 vaccine if it was offered for free by the Malaysian government. The median out-of-pocket cost that participants were willing to pay for a COVID-19 vaccine was Malaysian ringgit (MYR) 100 (interquartile range [IQR], 100) if it was readily available and MYR 150 (IQR, 200) if the supply was limited. Respondents with a low likelihood of vaccine hesitancy had 13 times higher odds of accepting the COVID-19 vaccine (95% confidence interval [CI], 8.69 to 19.13). High perceived risk and severity were also associated with willingness to be vaccinated, with adjusted odds ratios of 2.22 (95% CI, 1.44 to 3.41) and 2.76 (95% CI, 1.87 to 4.09), respectively. Age and ethnicity were the only independent demographic characteristics that predicted vaccine uptake.
Conclusion Public health strategies targeting perceived risk, perceived susceptibility and vaccine hesitancy could be effective in enhancing vaccine uptake.
Citations
Citations to this article as recorded by
COVID-19 vaccine uptake and its determinants among teenagers and their parents in Zhejiang, China: An online cross-sectional study Yu Huang, Qingqing Wu, Shuiyang Xu, Xiang Zhao, Lei Wang, Qiaohong Lv, Suxian Wu, Xuehai Zhang Asian Pacific Journal of Tropical Medicine.2023; 16(4): 176. CrossRef
Factors influencing parents’ hesitancy to vaccinate their children aged 5–11 years old against COVID-19: results from a cross-sectional study in Malaysia Roy Rillera Marzo, Ritankar Chakraborty, Shean Yih Soh, Hui Zhu Thew, Collins Chong, Ching Sin Siau, Khairuddin Bin Abdul Wahab, Indang Ariati Binti Ariffin, Shekhar Chauhan, Ken Brackstone, Bijaya Kumar Padhi, Petra Heidler Frontiers in Public Health.2023;[Epub] CrossRef
Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou Vacunas.2022; 23: S60. CrossRef
Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework Jason Wei Jian Ng, Santha Vaithilingam, Mahendhiran Nair, Li-Ann Hwang, Kamarul Imran Musa, Anat Gesser-Edelsburg PLOS ONE.2022; 17(5): e0268926. CrossRef
Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia Li Ping Wong, Haridah Alias, Yan-Li Siaw, Mustakiza Muslimin, Lee Lee Lai, Yulan Lin, Zhijian Hu Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis Ayenew Mose, Abebaw Wasie, Solomon Shitu, Kassahun Haile, Abebe Timerga, Tamirat Melis, Tadesse Sahle, Amare Zewdie, Dong Keon Yon PLOS ONE.2022; 17(6): e0269273. CrossRef
When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioural insights from a randomised controlled experiment in Malaysia Nicholas Yee Liang Hing, Yuan Liang Woon, Yew Kong Lee, Hyung Joon Kim, Nurhyikmah M Lothfi, Elizabeth Wong, Komathi Perialathan, Nor Haryati Ahmad Sanusi, Affendi Isa, Chin Tho Leong, Joan Costa-Font BMJ Global Health.2022; 7(7): e009250. CrossRef
COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis Getaneh Mulualem Belay, Tewodros Getaneh Alemu, Masresha Asmare Techane, Chalachew Adugna Wubneh, Nega Tezera Assimamaw, Tadesse Tarik Tamir, Addis Bilal Muhye, Destaye Guadie Kassie, Amare Wondim, Bewuketu Terefe, Bethlehem Tigabu Tarekegn, Mohammed Seid Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou Vacunas (English Edition).2022; 23: S60. CrossRef
Objectives The purposes of this study were to (1) examine the multi-year prevalence of highly caffeinated beverage (HCB) consumption, (2) identify sex differences in the prevalence, and (3) investigate relationships between HCB consumption and behavioral characteristics in a nationally representative sample of Korean adolescents.
Methods Data from the Korea Youth Risk Behavior Web-based Survey (2014–2017) were analyzed.
Results HCB consumption was higher in 2017 than 2014 (23.9% vs. 12.0%), and higher among boys than girls (17.2% vs. 13.1%). HCB drinkers were more likely to (1) be boys, (2) be overweight or obese, (3) use alcohol and tobacco, (4) consume soda at least once per week, (5) consume sweetened beverages at least once per week, (6) have seriously considered suicide during the past 12 months, and (7) have attempted suicide during the past 12 months (p<0.05 for all).
Conclusion Effective programs to curb HCB consumption among Korean adolescents need to be established.
Citations
Citations to this article as recorded by
Secondary School Students and Caffeine: Consumption Habits, Motivations, and Experiences Sophie Turner, Ajmol Ali, Carol Wham, Kay Rutherfurd-Markwick Nutrients.2023; 15(4): 1011. CrossRef
Objectives Herpes simplex virus (HSV) infections have been reported in 60% to 95% of the adult population worldwide, making them one of the most common infectious conditions globally. HSV-1 and HSV-2 cause severe disease in immunocompromised patients. Therefore, the aim of this study was to provide information that could be used to reduce the incidence of genital herpes caused by HSV-1 and HSV-2.
Methods From September 2018 to December 2020, 59,381 specimens were collected from outpatients across primary and secondary hospitals in Korea who requested U2Bio (Seoul, Korea) to conduct molecular biological testing of their samples for sexually transmitted infections. In this study, the positivity rates of HSV-1 and HSV-2 were analyzed according to age, sex, and specimen type.
Results In the age-specific analysis of HSV-1, the highest positivity rate (0.58%) was observed in patients under 19 years of age, whereas the lowest positivity rate (0.08%) was observed in patients aged over 70 years. In the age-specific analysis of HSV-2, the highest positivity rate (2.53%) was likewise observed in patients under 19 years of age.
Conclusion Our study identified differences in the infection rates of HSV-1 and HSV-2 depending on patients’ sex and age. These differences will be useful for improving disease prevention and control measures for HSV-1 and HSV-2.
Objectives This study was undertaken to evaluate AmpC β-lactamase-producing Escherichia coli urine isolates and to characterize the frequency of plasmid-mediated AmpC (pAmpC)-encoding genes.
Methods Antimicrobial susceptibility tests were performed using the disk diffusion technique. AmpC β-lactamase production was assessed with a phenotypic inhibitor-based method. The presence of 6 pAmpC-encoding cluster genes was detected by multiplex polymerase chain reaction (PCR).
Results The proportion of antibiotic resistance of E. coli isolates ranged from 7.4% to 90.5%, and more than half (51.6%) of the total isolates were multidrug-resistant (MDR). Among the 95 E. coli isolates, 60 (63.2%) were found to be cefoxitin-resistant, but only 14 (14.7%) isolates were confirmed as AmpC β-lactamase-producers. In the PCR assay, pAmpC-encoding genes were found in 15 (15.8%) isolates, and blaDHA was the most prevalent type. However, blaFOX, blaMOX, and blaACC genes were not detected in the isolates.
Conclusion Our findings contributed valuable information concerning antibiotic resistance, confirmatory phenotypic testing for AmpC production, and pAmpC β-lactamase gene content in E. coli isolates in southwestern Iran. The level of MDR recorded in AmpC-producing strains of this study was worrying; therefore, implementing strong infection control approaches to reduce the MDR burden is recommended.
Citations
Citations to this article as recorded by
Prevalence of Extended-Spectrum β-Lactamase-Resistant Genes in Escherichia coli Isolates from Central China during 2016–2019 Zui Wang, Qin Lu, Xiaohui Mao, Li Li, Junfeng Dou, Qigai He, Huabin Shao, Qingping Luo Animals.2022; 12(22): 3191. CrossRef
Molecular detection and characterization of Shigella spp. harboring extended-spectrum β-lactamase genes in children with diarrhea in northwest Iran Sahar Sabour, Amir Teimourpour, Jafar Mohammadshahi, Hadi Peeridogaheh, Roghayeh Teimourpour, Taher Azimi, Zahra Hosseinali Molecular and Cellular Pediatrics.2022;[Epub] CrossRef
Plasmid-mediated AmpC β-Lactamase gene analysis in Klebsiella Pneumoniae clinical isolates Nabi Jomehzadeh, Khadijeh Ahmadi, Hasti Shaabaninejad, Gholamali Eslami Biomedical and Biotechnology Research Journal (BBR.2022; 6(4): 582. CrossRef
Objectives This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an analysis of the characteristics of suspected adverse event cases for each type of vaccine.
Methods Adverse events following COVID-19 vaccination reported by medical doctors and forensic pathologists were analyzed. Cases of suspected anaphylaxis were classified using the Brighton Collaboration definition.
Results By October 31, 2021, a total of 353,535 (0.45%) adverse events were reported after 78,416,802 COVID-19 vaccine doses. Of the adverse events, 96.4% were non-serious and 3.6% were serious. The most frequently reported adverse events were headache, myalgia, and dizziness. Of the 835 reported deaths after COVID-19 vaccination, 2 vaccine-related deaths were confirmed. Suspected anaphylaxis was confirmed in 454 cases using the Brighton Collaboration definition.
Conclusion The commonly reported symptoms were similar to those described in clinical trials. Most reported adverse events were non-serious, and the reporting rate of adverse events following COVID-19 vaccination was higher in women than in men (581 vs. 315 per 100,000 vaccinations). Confirmed anaphylaxis was reported in 5.8 cases per 1,000,000 vaccinations.
Citations
Citations to this article as recorded by
A Nationwide Survey of mRNA COVID-19 Vaccinee’s Experiences on Adverse Events and Its Associated Factors Dongwon Yoon, Ha-Lim Jeon, Yunha Noh, Young June Choe, Seung-Ah Choe, Jaehun Jung, Ju-Young Shin Journal of Korean Medical Science.2023;[Epub] CrossRef
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management Nicoletta Luxi, Alexia Giovanazzi, Alessandra Arcolaci, Patrizia Bonadonna, Maria Angiola Crivellaro, Paola Maria Cutroneo, Carmen Ferrajolo, Fabiana Furci, Lucia Guidolin, Ugo Moretti, Elisa Olivieri, Giuliana Petrelli, Giovanna Zanoni, Gianenrico Senna, BioDrugs.2022; 36(4): 443. CrossRef
Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea Seontae Kim, Insob Hwang, Mijeong Ko, Yunhyung Kwon, Yeon-Kyeng Lee Osong Public Health and Research Perspectives.2022; 13(3): 230. CrossRef
Incidence and Characteristics of Adverse Events after COVID-19 Vaccination in a Population-Based Programme Laura Bonzano, Olivera Djuric, Pamela Mancuso, Lidia Fares, Raffaele Brancaccio, Marta Ottone, Eufemia Bisaccia, Massimo Vicentini, Alessia Cocconcelli, Alfonso Motolese, Rostyslav Boyko, Paolo Giorgi Rossi, Alberico Motolese Vaccines.2022; 10(7): 1111. CrossRef
Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review Carla Pires Vaccines.2022; 10(8): 1349. CrossRef
Anaphylaxis and Related Events Following COVID‐19 Vaccination: A Systematic Review Pradipta Paul, Emmad Janjua, Mai AlSubaie, Vinutha Ramadorai, Beshr Mushannen, Ahamed Lazim Vattoth, Wafa Khan, Khalifa Bshesh, Areej Nauman, Ibrahim Mohammed, Imane Bouhali, Mohammed Khalid, Dalia Zakaria The Journal of Clinical Pharmacology.2022; 62(11): 1335. CrossRef
Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years Seontae Kim, Yeseul Heo, Soon-Young Seo, Do Sang Lim, Enhi Cho, Yeon-Kyeng Lee Osong Public Health and Research Perspectives.2022; 13(5): 382. CrossRef
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward Eliel Nham, Joon Young Song, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim Journal of Korean Medical Science.2022;[Epub] CrossRef
Self-reported Adverse events following the second dose of COVID-19 Vaccines in the Republic of Korea: Recipient survey, February to December 2021 Yunhyung Kwon, Insob Hwang, Mijeong Ko, Hyungjun Kim, Seontae Kim, Soon-Young Seo, Enhi Cho, Lee Yeon-Kyeng Epidemiology and Health.2022; : e2023006. CrossRef